John C Jacobs Novavax Inc (NVAX) insider trading activity

John C Jacobs is President and CEO of NOVAVAX INC. Currently has a direct ownership of 136,732 shares of NVAX, which is worth approximately $1.04 Million. The most recent transaction as insider was on Mar 01, 2025, when has been sold 38,451 shares (Common Stock) at a price of $8.33 per share, resulting in proceeds of $320,296. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 137K

217.21% 3M change

217.21% 12M change

Total Value Held $1.04 Million

John C Jacobs Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 01 2025	SELL Payment of exercise price or tax liability	$320,296 $8.33 p/Share	38,451 Reduced 21.95%	136,732 Common Stock
Mar 01 2025	BUY Exercise of conversion of derivative security	-	83,334 Added 32.24%	175,183 Common Stock
Jan 23 2025	SELL Payment of exercise price or tax liability	$371,237 $9.55 p/Share	38,873 Reduced 29.74%	91,849 Common Stock
Jan 23 2025	BUY Exercise of conversion of derivative security	-	83,196 Added 38.89%	130,722 Common Stock
Jan 23 2024	SELL Payment of exercise price or tax liability	$170,796 $4.26 p/Share	40,093 Reduced 48.19%	43,104 Common Stock
Jan 23 2024	BUY Exercise of conversion of derivative security	-	83,197 Added 50.0%	83,197 Common Stock

Also insider at

HRMY

Harmony Biosciences Holdings, Inc. Healthcare

PRESIDENT, CEO

JCJ

John C Jacobs

President and CEO

Plymouth Meeting, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVAX shares.

Notify only if

Value

Insider Trading

Get notified when an Novavax Inc insider buys or sells NVAX shares.

Notify only if

Operation

Value

Type

News

Receive news related to NOVAVAX INC

Track Activities on NVAX

Account